Terri Gaskell
Company: Rinri Therapeutics
Job title: Chief Technology Officer
Seminars:
Accounting for Method & Definition Variation in Potency Assays Caused by Different Engineering Approaches to Enhance Assay Development 2:30 pm
By addressing the impact of different engineering approaches on potency assays, and discussing best practices for improving assay accuracy and reproducibility, this workshop can help ensure cell-based therapies are developed and tested to the highest standards of safety and efficacy. Attend this workshop to: Explore the impact of different engineering approaches on potency assays and…Read more
day: Pre-Conference Workshop Day
Gaining Control of your Manufacturing Process with Clear CQAs, Controlling Advantageous Agents in Biologics 9:30 am
Understanding the principles of critical quality attributes and their role in controlling the manufacturing process of biologics Exploring the challenges and best practices in identifying and controlling advantageous agents in biologics Discussing case studies and success stories of applying CQA and advantageous agent control in cell therapy manufacturing processesRead more
day: Conference Day One